Skip to content

Boston Scientific BSX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.34B+99.9%$670M-11.3%$755M-5.0%$795M+18.3%$672M+19.6%
$351M-3.8%$365M+6.7%$342M+1.8%$336M+3.4%$325M-6.6%
$83M+16.9%$71M-10.1%$79M+5.3%$75M+1.4%$74M+7.2%
$348M-74.5%$1.36B+1.6%$1.34B+4.4%$1.29B+138%$541M-62.8%
$177M-49.6%$351M+93.9%$181M+15.3%$157M-16.0%$187M-32.5%
$523M+488%$89M-65.2%$256M-74.6%$1.01B+322%$239M-93.0%
-$591M-15.4%-$512M-2.0%-$502M+55.4%-$1.13B-125%-$500M+86.5%
-$260M-41.3%-$184M-76.9%-$104M+69.4%-$340M-246%$233M+8.9%
-$504M-175%$671M-8.7%$735M$314M+115%
$171M-83.1%$1.01B-12.8%$1.16B+2.9%$1.13B+219%$354M-70.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Boston Scientific generate?
Boston Scientific (BSX) generated $4.3B in operating cash flow over the trailing twelve months.
What is Boston Scientific's free cash flow?
After $866.0M of capital expenditures, Boston Scientific's free cash flow was $3.5B over the trailing twelve months, up 15.3% year over year.
Where does Boston Scientific's cash flow data come from?
Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.